Qiagen
QGEN
231 hedge funds and large institutions have $4.6B invested in Qiagen in 2018 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 82 reducing their positions, and 22 closing their positions.
86% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 22
7% more funds holding
Funds holding: 215 → 231 (+16)
4% more capital invested
Capital invested by funds: $4.43B → $4.6B (+$175M)
0.27% more ownership
Funds ownership: 59.05% → 59.32% (+0.27%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 82
82% less call options, than puts
Call options by funds: $4.31M | Put options by funds: $24.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$66.5M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$52.9M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$33.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$32.4M |
| 5 |
Goldman Sachs
New York
|
+$27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$109M |
| 2 |
JP Morgan Chase
New York
|
-$37.5M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$36.7M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$35.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$28.7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
251
Credit Agricole
Montrouge Cedex,
France
| – | +$70 | +2 | New |
|
|
AC
252
Avestar Capital
New York
| – | +$808 | +23 | New |
|
|
SPIA
253
Steward Partners Investment Advisory
New York
| – | +$808 | +23 | New |
|
QGEN Hedge Fund Activity: Q1 2018 in Review
231 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q1 2018, worth a combined $4.6B — up 3.9% from $4.43B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new QGEN positions and 22 closed out — a net gain of 19 holders — while 65 added to existing stakes and 82 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $66.5M. The largest seller was BlackRock, cutting an estimated $109M.
- 231 institutional investors held Qiagen (QGEN) as of Q1 2018, up from 215 in Q4 2017.
- Funds reported $4.6B of Qiagen stock for Q1 2018, up 3.9% quarter-over-quarter.
- 41 funds opened new Qiagen positions in Q1 2018 and 22 closed out, a net change of +19 holders.
- The largest Qiagen buyer in Q1 2018 was HealthCor Management, an estimated $66.5M added.
- The largest Qiagen seller in Q1 2018 was BlackRock, an estimated $109M sold.
Based on aggregated 13F filings for Q1 2018.